PANCREAS CANCER, METASTATIC
Clinical trials for PANCREAS CANCER, METASTATIC explained in plain language.
Never miss a new study
Get alerted when new PANCREAS CANCER, METASTATIC trials appear
Sign up with your email to follow new studies for PANCREAS CANCER, METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to tackle deadly pancreatic cancer
Disease control Not yet recruitingThis study tests a new drug called samuraciclib added to standard chemotherapy for people with a specific type of advanced pancreatic cancer (basal-like). The goal is to find the safest dose and see if the combination helps shrink tumors or slow the cancer. About 67 adults with n…
Matched conditions: PANCREAS CANCER, METASTATIC
Phase: PHASE1, PHASE2 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New cell therapy trial hopes to tackle tough cancers
Disease control Not yet recruitingThis early-phase trial tests SL-28, a cell therapy made from donor immune cells, in 60 people with advanced solid tumors (like lung, pancreatic, or breast cancer) that haven't responded to standard treatments. The study aims to find a safe dose and see if the therapy can shrink t…
Matched conditions: PANCREAS CANCER, METASTATIC
Phase: PHASE1, PHASE2 • Sponsor: Second Life Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC